Presented:
Type: Poster, MultiOmyx
PD-1 and LAG-3 synergize to drive tumor-infiltration of T cytotoxic cells in NSCLC tumors
Presented at European Society For Medical Oncology (ESMO) Immuno-Oncology Congress
Presented:
Type: Poster
A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3
Presented at 2019 San Antonio Breast Cancer Symposium
Presented:
Type: Poster, MultiOmyx
An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors
Presented at The Society for Immunotherapy of Cancer (SITC)
Presented:
Type: Poster, MultiOmyx
An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors
Presented at European Organisation for Research and Treatment of Cancer
Presented:
Type: Publication
The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression
Published editorial in Oncogene
Presented:
Type: Publication
EBV–Associated Lymphoproliferative Disorders: Update in Classification
Published in Surgical Pathology Clinics, September 2019
Presented:
Type: Poster, MultiOmyx
Using a Multiplexed Immunofluorescence Approach to Compare Immune Cell Populations in Subtypes on Non-Small Cell Lung Cancer
Presented at World Conference on Lung Cancer (WCLC)
Presented:
Type: MultiOmyx, Poster
Characterization of TIGIT Expression Using MultiOmyx™ Hyperplexed Immunofluorescence Assay in NSCLC and melanoma
Presented at AACR 2019
Presented:
Type: Publication
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
Published in Cancer Immunology Research, April 2019
Presented:
Type: MultiOmyx, Poster
Pro-Tumorigenic Mechanisms of M2 Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Presented at AACR 2019